BSD Medical Applies for FDA Approval of the BSD-2000 Cancer Treatment System

BSD Medical Corp. (AMEX: BSM) todayannounced that the company has sent to the U.S. Food and DrugAdministration (FDA) a PreMarket Approval Application (PMAA) for thecompany's BSD-2000 cancer treatment system. FDA approval of thisapplication would allow commercial sales of the BSD-2000 in the UnitedStates.

The BSD-2000 delivers precision-focused RF energy in cancerous tumors, andwas developed particularly to allow treatment access for cancer locateddeep in the body. The BSD-2000 technology applies principles also used indeep-space radio telescopes and advanced phased-array communications,creating a unique cancer treatment capability. Frost and Sullivanpresented to BSD the Technology Innovation of the Year Award for cancertherapy devices based on the contribution of the BSD-2000 in theadvancement of cancer therapy and the creation of new business opportunity.

Highlighted Links BSD Medical Corporation

MacReport.Net

Thousands of cancer patients have been treated with the BSD-2000 atprestigious cancer centers in many parts of the world as well as the UnitedStates. BSD Medical acknowledges the generous support that has beenprovided by the National Institutes of Health (NIH) in the United States,the Dutch National Health Insurance Council (Nederlandse Ziekenfondsraad),the German Federal Research Council (DFG Deutsche Forschungsgemeinschaft)and the German Cancer Aid Foundation (Stiftung Deutsche Krebshilfe e.V.) infunding cancer research using the BSD-2000 cancer treatment system.

After receipt, FDA will review the submission to determine its completenessand adequacy for filing. The submission (consisting of 7,243 pagescontained in 24 volumes) was expanded considerably, as compared to theoriginal planned submission, to include testing for system enhancements tothe BSD-2000, and therefore contains all of the upgrades envisioned for thecommercial version of the BSD-2000.

BSD Medical is the leading developer of precision-focused microwave/RFsystems used in the treatment of cancer. For further information visit theBSD website at www.BSDMedical.com.

Statements contained in this press release that are not historical factsare forward-looking statements, as that item is defined in the PrivateSecurities Litigation Reform Act of 1995. All forward-looking statements,including all projections and expectations of future events, including FDAapproval of the BSD-2000, are subject to risks and uncertainties, detailedin the Company's filings with the Securities and Exchange Commission.

Contact:Hyrum A. MeadTelephone: (801) 972-5555Facsicmile: (801) 972-5930Email: investor@bsdmc.com

BSD Medical Corporation2188 West 2200 SouthSalt Lake City, Utah 84119-1326

SOURCE:  BSD Medical Corp.

Related Articles

• Microsoft Increases Investments in System Builder and Distributor Channels
  Thursday, 9 March 2006



• Boston Software Systems Enables Biometric Authentication With CPOE System
  Saturday, 4 March 2006



• Oracle(r) Enterprise Manager Introduces Systems Management Capabilities for Microsoft .NET Framework and Microsoft Windows Server System
  Thursday, 2 March 2006



• Democracy Internet TV Launches 'TiVo for Web Video' System
  Thursday, 2 March 2006



• New Sun Java System RFID Software 3.0 Lets Enterprises Take RFID to the Physical Edge More Easily and Quickly
  Wednesday, 1 March 2006



• Green Hills Software Announces New Development Tools and Operating System for Texas Instruments DaVinci(TM) Technology
  Wednesday, 1 March 2006



• Swedish National Supercomputing Center to Tackle Large-Scale Problems With New SGI Altix System
  Wednesday, 1 March 2006



• Lustre Users Worldwide Confirm Exceptional File System Stability
  Wednesday, 22 February 2006



• Announcing First Ever Computer Burglar Alarm plus System Organizer and Sealer Offered by QCF
  Sunday, 19 February 2006



• GIPS Advances Leadership Position in Mobile Phone Market Through Partnership With Leading Real-Time Operating System Developer
  Saturday, 18 February 2006



• Xilinx Streamlines Embedded System Design With New Platform Studio Version 8.1i
  Wednesday, 15 February 2006



• Smart Style Selects Continuent Clustering for MySQL
  Wednesday, 15 February 2006



• Nokia and MySQL Collaborate on Next Generation Telecommunication Subscriber Registers
  Wednesday, 15 February 2006



• Sun Microsystems Solves Customers' Business Integration Challenges; Strengthens Solaris Enterprise System with New Sun Java Composite Application Plat
  Sunday, 12 February 2006



• BSD Medical Launches Campaign to Take Its Cancer Therapy to Patients
  Friday, 10 February 2006